AAAAAA
Results: 51-75/105
Authors:
Mouatt-Prigent, A
Karlsson, JO
Yelnik, J
Agid, Y
Hirsch, EC
Citation: A. Mouatt-prigent et al., Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease, J COMP NEUR, 419(2), 2000, pp. 175-192
Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease
Authors:
Dubus, P
Faucheux, B
Boissiere, F
Groppi, A
Vital, C
Vital, A
Agid, Y
Hirsch, EC
Merlio, JP
Citation: P. Dubus et al., Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease, EXP NEUROL, 165(2), 2000, pp. 285-294
Authors:
Perier, C
Vila, M
Feger, J
Agid, Y
Hirsch, EC
Citation: C. Perier et al., Functional activity of zona incerta neuron is altered after nigrostriatal denervation in hemiparkinsonian rats, EXP NEUROL, 162(1), 2000, pp. 215-224
Authors:
Zalla, T
Sirigu, A
Pillon, B
Dubois, B
Agid, Y
Grafman, J
Citation: T. Zalla et al., How patients with Parkinson's disease retrieve and manage cognitive event knowledge, CORTEX, 36(2), 2000, pp. 163-179
Authors:
Tassin, J
Durr, A
Bonnet, AM
Gil, R
Vidailhet, M
Lucking, CB
Goas, JY
Durif, F
Abada, M
Echenne, B
Motte, J
Lagueny, A
Lacomblez, L
Jedynak, P
Bartholome, B
Agid, Y
Brice, A
Citation: J. Tassin et al., Levodopa-responsive dystonia - GTP cyclohydrolase I or parkin mutations?, BRAIN, 123, 2000, pp. 1112-1121
Authors:
Kubis, N
Faucheux, BA
Ransmayr, G
Damier, P
Duyckaerts, C
Henin, D
Forette, B
Le Charpentier, Y
Hauw, JJ
Agid, Y
Hirsch, EC
Citation: N. Kubis et al., Preservation of midbrain catecholaminergic neurons in very old human subjects, BRAIN, 123, 2000, pp. 366-373
Authors:
Cancel, G
Duyckaerts, C
Holmberg, M
Zander, C
Yvert, G
Lebre, AS
Ruberg, M
Faucheux, B
Agid, Y
Hirsch, E
Brice, A
Citation: G. Cancel et al., Distribution of ataxin-7 in normal human brain and retina, BRAIN, 123, 2000, pp. 2519-2530
Authors:
Houeto, JL
Damier, P
Bejjani, PB
Staedler, C
Bonnet, AM
Arnulf, I
Pidoux, B
Dormont, D
Cornu, P
Agid, Y
Citation: Jl. Houeto et al., Subthalamic stimulation in Parkinson disease - A multidisciplinary approach, ARCH NEUROL, 57(4), 2000, pp. 461-465
Authors:
Brassat, D
Camuzat, A
Vidailhet, M
Feki, I
Jedynak, P
Klap, P
Agid, Y
Durr, A
Brice, A
Citation: D. Brassat et al., Frequency of the DYT1 mutation in primary torsion dystonia without family history, ARCH NEUROL, 57(3), 2000, pp. 333-335
Authors:
Agid, Y
Citation: Y. Agid, Will neurological practice be different during the 21st century?, ARCH NEUROL, 57(1), 2000, pp. 56-57
Authors:
Stevanin, G
David, G
Durr, A
Giunti, P
Benomar, A
Abada-Bendib, M
Lee, MS
Agid, Y
Brice, A
Citation: G. Stevanin et al., Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers, including an intragenic polymorphism (G(3145)TG/A(3145)TG), EUR J HUM G, 7(8), 1999, pp. 889-896
Authors:
Abbas, N
Lucking, CB
Ricard, S
Durr, A
Bonifati, V
De Michele, G
Bouley, S
Vaughan, JR
Gasser, T
Marconi, R
Broussolle, E
Brefel-Courbon, C
Harhangi, BS
Oostra, AB
Fabrizio, E
Bohme, GA
Pradier, L
Wood, NW
Filla, A
Meco, G
Denefle, P
Agid, Y
Brice, A
Citation: N. Abbas et al., A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe, HUM MOL GEN, 8(4), 1999, pp. 567-574
Authors:
Rosler, M
Anand, R
Cicin-Sain, A
Gauthier, S
Agid, Y
Dal-Bianco, P
Stahelin, HB
Hartman, R
Gharabawi, M
Citation: M. Rosler et al., Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial, BR MED J, 318(7184), 1999, pp. 633-638
Authors:
Murer, MG
Raisman-Vozari, R
Yan, Q
Ruberg, M
Agid, Y
Michel, PP
Citation: Mg. Murer et al., Survival factors promote BDNF protein expression in mesencephalic dopaminergic neurons, NEUROREPORT, 10(4), 1999, pp. 801-805
Authors:
Parain, K
Murer, MG
Yan, Q
Faucheux, B
Agid, Y
Hirsch, E
Raisman-Vozari, R
Citation: K. Parain et al., Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra, NEUROREPORT, 10(3), 1999, pp. 557-561
Authors:
Agid, Y
Ahlskog, E
Albanese, A
Calne, D
Chase, T
De Yebenes, J
Factor, S
Fahn, S
Gershanik, O
Goetz, C
Koller, W
Kurth, M
Lang, A
Lees, A
Lewitt, P
Marsden, D
Melamed, E
Michel, PP
Mizuno, Y
Obeso, J
Oertel, W
Olanow, W
Poewe, W
Pollak, P
Przedzorski, S
Quinn, N
Raisman-Vozari, R
Rajput, A
Stocchi, F
Tolosa, E
Citation: Y. Agid et al., Levodopa in the treatment of Parkinson's disease: A consensus meeting, MOVEMENT D, 14(6), 1999, pp. 911-913
Authors:
Sabbagh, N
Brice, A
Marez, D
Durr, A
Legrand, M
Lo Guidice, JM
Destee, A
Agid, Y
Broly, F
Citation: N. Sabbagh et al., CYP2D6 polymorphism and Parkinson's disease susceptibility, MOVEMENT D, 14(2), 1999, pp. 230-236
Authors:
Durif, F
Vidailhet, M
Debilly, B
Agid, Y
Citation: F. Durif et al., Worsening of levodopa-induced dyskinesias by motor and mental tasks, MOVEMENT D, 14(2), 1999, pp. 242-245
Authors:
Hirsch, EC
Hunot, S
Faucheux, B
Agid, Y
Mizuno, Y
Mochizuki, H
Tatton, WG
Tatton, N
Olanow, WC
Citation: Ec. Hirsch et al., Dopaminergic neurons degenerate by apoptosis in Parkinson's disease, MOVEMENT D, 14(2), 1999, pp. 383-384
Authors:
Agid, Y
Destee, A
Durif, F
Montastruc, JL
Pedarriosse, AM
Deptula, D
Hoffman-La Roche, F
Pollak, P
Bonnet, AM
Allain, H
le Cavorzin, P
Barroche, G
Blin, O
Cesaro, P
Chazot, G
Broussolle, E
Leduc, V
Debilly, B
Feve, JR
Geraud, G
Fabre, N
Gu, C
Gil, R
Henry, P
Tison, F
Ansquer, O
Brefel, C
Payen, I
Said, G
Plante, V
Touchon, J
Cesari, JB
Camu, W
Bennys, K
Viallet, F
Warter, JM
Tranchant, C
Ziegler, M
Citation: Y. Agid et al., Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients, MOVEMENT D, 14(1), 1999, pp. 38-44
Authors:
Vidailhet, M
Bonnet, AM
Marconi, R
Durif, F
Agid, Y
Citation: M. Vidailhet et al., The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease, MOVEMENT D, 14, 1999, pp. 13-18
Authors:
Damier, P
Jaillon, C
Clavier, I
Arnulf, I
Bonnet, AM
Bejjani, BP
Agid, Y
Citation: P. Damier et al., Dyskinesias assessment in Phase II studies, MOVEMENT D, 14, 1999, pp. 54-59
Authors:
Agid, Y
Citation: Y. Agid, Parkinson's disease or Parkinson's diseases?, BIOMED PHAR, 53(7), 1999, pp. 301-302
Authors:
Ardouin, C
Pillon, B
Peiffer, E
Bejjani, P
Limousin, P
Damier, P
Arnulf, I
Benabid, AL
Agid, Y
Pollak, P
Citation: C. Ardouin et al., Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: A consecutive series of 62 patients, ANN NEUROL, 46(2), 1999, pp. 217-223
Authors:
Muriel, MP
Bernard, V
Levey, AI
Laribi, O
Abrous, DN
Agid, Y
Bloch, B
Hirsch, EC
Citation: Mp. Muriel et al., Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease, ANN NEUROL, 46(1), 1999, pp. 103-111